The best peptides for sleep, judged by evidence, depend on the sleep problem. For chronic insomnia, no peptide is proven, and the recommended first treatment is cognitive behavioral therapy for insomnia (CBT-I).[1] For obstructive sleep apnea in adults with obesity, the peptide drug tirzepatide (Zepbound) is FDA-approved and reduced breathing interruptions by 20 to 24 more events an hour than placebo.[3][4] DSIP and growth hormone peptides rest on small, mixed studies.[8]
Peptides are heavily marketed for “deep sleep” and recovery. This guide separates what is proven from what is not, and explains how orexin, a brain peptide, became the target of approved sleep pills. For related compounds, see the nootropic peptides hub.
Best peptides for sleep: evidence at a glance
| Treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| CBT-I (not a drug) | Human RCTs; first-line care | Recommended first treatment for chronic insomnia[1] | Not a drug | — |
| Tirzepatide (for sleep apnea) | FDA-approved for this use | Cut apnea events by 20 to 24 per hour more than placebo[4] | Approved for moderate to severe OSA with obesity[3] | Tirzepatide |
| Orexin blockers (suvorexant, lemborexant, daridorexant) | FDA-approved for this use (non-peptide drugs) | Faster sleep onset and less night waking over 3 months[6][7] | Approved for insomnia | — |
| MK-677 (ibutamoren) | Small human studies | More deep and REM sleep in 14 volunteers[10] | Not approved | MK-677 |
| GHRH-type peptides (sermorelin, CJC-1295) | Small human studies | Mixed: GHRH impaired sleep in young women[11] | Not approved for sleep | Sermorelin |
| DSIP | Small human studies | Weak, inconsistent effects in tiny IV trials[8][9] | Not approved; advisers voted against compounding[14] | DSIP |
| Epitalon | No evidence, marketing only | No clinical studies in insomnia[13] | Not approved | Epitalon |
Start with what works
CBT-I teaches techniques such as keeping a consistent wake time, limiting time awake in bed and reframing worries about sleep. The American College of Physicians recommends it as the initial treatment for all adults with chronic insomnia, a strong recommendation, and suggests adding medicine only through shared decision-making if CBT-I alone does not work.[1]
Treat sleep apnea if you have it. Tirzepatide is a GLP-1 and GIP peptide drug. In the SURMOUNT-OSA trials, adults with moderate-to-severe sleep apnea and obesity started with about 50 breathing interruptions an hour. After 52 weeks, tirzepatide reduced them by 25 to 29 events an hour versus about 5 with placebo, with gut side effects most common.[4] It is approved for this use alongside diet and exercise.[3] Our Zepbound sleep apnea guide covers coverage and dosing.
Orexin: the brain peptide behind approved sleep pills
Orexin A and orexin B are brain peptides that promote wakefulness. Three approved insomnia drugs, suvorexant (Belsomra), lemborexant (Dayvigo) and daridorexant (Quviviq), work by blocking their receptors. The drugs themselves are not peptides.[5][15][16]
- Suvorexant: two 3-month trials with about 2,000 patients found better sleep onset and maintenance than placebo, and fewer than 5% stopped because of side effects.[6]
- Daridorexant: two phase 3 trials with more than 1,800 patients found the 50 mg dose reduced night waking by about 23 minutes more than placebo at one month.[7]
The American Academy of Sleep Medicine’s 2017 guideline reviewed individual insomnia drugs, including suvorexant, and graded each on benefit and harm.[2] These drugs can cause next-day drowsiness, so they are prescription medicines for a reason.
The peptides marketed for sleep
DSIP
DSIP, delta sleep-inducing peptide, was named for its effect on rabbit brain waves. FDA’s 2026 review counted only 209 people who had ever received it by IV and called its effects on disturbed sleep “inconclusive and at best preliminary.”[8] In a 1992 double-blind trial of 16 people with chronic insomnia, IV DSIP produced weak effects that may have reflected a chance change in the placebo group, and the authors concluded it was unlikely to be of major benefit.[9] FDA advisers voted 6 to 7 against adding it to the compounding list in July 2026.[14] Our DSIP vs melatonin comparison goes deeper.
Growth hormone secretagogues
Deep sleep and growth hormone release are linked, so GH-boosting compounds are sold as sleep aids.
- MK-677, an oral GH secretagogue (not technically a peptide), increased deep stage 4 sleep by about 50% and REM sleep by more than 20% in eight young adults, and raised REM sleep in six older adults.[10]
- GHRH, the hormone that sermorelin and CJC-1295 mimic, deepens sleep in young men in some studies, but in a 2007 randomized study it impaired sleep in healthy young women.[11] In young men, blocking natural GHRH strongly suppressed growth hormone release but did not change deep sleep, suggesting GHRH is not what drives it.[12]
None of these is approved for sleep, and the studies were tiny. Our MK-677 vs CJC-1295/ipamorelin comparison covers side effects such as raised blood sugar and fluid retention.
Epitalon
Epitalon is promoted for sleep because it may influence melatonin. FDA found no clinical studies of epitalon in insomnia; the one human study it found measured a melatonin breakdown product in women who mostly worked night shifts, not sleep itself.[13] Even so, FDA advisers voted 7 to 4 to recommend it for compounding for insomnia.[14]
Why “deep sleep” peptide claims are hard to trust
Most peptide sleep claims rest on brain-wave changes in a sleep lab, often in a handful of healthy volunteers for a few nights. That is not the same as helping someone with chronic insomnia feel rested over months. DSIP studies used IV infusions, while DSIP products sold online are injected under the skin or sprayed in the nose, routes never tested for sleep.[8] Placebo effects in insomnia are real, too, so a product can seem to work for a week without doing anything. For DSIP, the positive results came mostly from small, early studies, and the better-controlled trial found little benefit.[9]
Questions for your clinician
- Could I have sleep apnea, restless legs or a body-clock disorder rather than insomnia?
- Can I get CBT-I, in person or through a digital program?
- If I need medicine, which option fits my health and other medicines?
- Is any peptide I am considering safe with my blood sugar, heart health and sedatives?
The bottom line
The best-supported sleep treatments are CBT-I for insomnia, approved orexin-blocking pills when medicine is needed, and tirzepatide for sleep apnea with obesity. DSIP and growth hormone peptides have only small, mixed studies, and epitalon has none in insomnia. Related reading: Selank vs Semax and Dihexa vs Semax vs Selank.
This is general information, not medical advice.
